QQ客服 官方微博 反馈留言

	A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.
	Li, Meifang; Yang, Jilong; Zhang, Lenghe; Tu, Sanfang; Zhou, Xuan; Tan, Ze; Zhou, Weijun; He, Yanjie; Li, Yuhua
刊名	Journal of Experimental & Clinical Cancer Research
	2019
卷号	Vol.38 No.1
关键词	Breast cancer Epidermal growth factor receptor (EGFR) Epidermal growth factor receptor pathway substrate 8 (Eps8) NSCLC, small-molecule inhibitor
ISSN号	1756-9966
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4609890
专题	湖南大学
作者单位	1.Department of Hematology, Zhujiang Hospital, Southern Medical University, No. 253 GongyeDadaoZhong, 510282, Guangzhou, Guangdong, People’s Republic of China 2.State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, 410082, Changsha, People’s Republic of China
推荐引用方式 GB/T 7714	Li, Meifang,Yang, Jilong,Zhang, Lenghe,et al. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.[J]. Journal of Experimental & Clinical Cancer Research,2019,Vol.38 No.1.
APA	Li, Meifang.,Yang, Jilong.,Zhang, Lenghe.,Tu, Sanfang.,Zhou, Xuan.,...&Li, Yuhua.(2019).A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation..Journal of Experimental & Clinical Cancer Research,Vol.38 No.1.
MLA	Li, Meifang,et al."A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.".Journal of Experimental & Clinical Cancer Research Vol.38 No.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。